---
$id: https://graph.org.ai/products/commodity/51111848
$type: Product
source: UNSPSC
code: "51111848"
title: "Formestane"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Formestane

**UNSPSC Code**: 51111848
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a steroidal aromatase inhibitor with the molecular formula C19H26O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PUB9T8T355, chemically known as 4-hydroxyandrost-4-ene-3,17-dione but generally known as formestane, which bears US NIH Compound Identifier 11273. European Medicines Agency schedules Formestane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07784MIG. The term FORMESTANE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, No, 3 1992, List 32). World Health Organization schedules formestane in its Anatomical Therapeutic Chemical (ATC) Classification. FORMESTANE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule formestane under HS 29372300 and SITC 54153. As of Q4 2014, FORMESTANE remains the US FDA Preferred Term for this commodity. Formestane bears US NLM identifiers UMLS ID C0048306 and NCI Concept Code C974. SMILES: O=C1C2(C(C3C(C4(C(=C(O)C(=O)CC4)CC3)C)CC2)CC1)C.

